68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT, covering 2026-08-12 to 2026-08-12. Get the full timeline:
Most recent: Clinical Trial Results: 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer [Phase 2]